首页 > 最新文献

Diseases of the Colon & Rectum最新文献

英文 中文
Clinicopathological Characteristics and Outcomes of Colorectal Cancer With Heterogenous Staining of Mismatch Repair Protein. 错配修复蛋白异质性染色的结直肠癌临床病理特征和预后
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-09-27 DOI: 10.1097/DCR.0000000000003527
Xian Zhang, Yu-Jue Wang, Lin-Yong Sun, Yin-Xia Tu, Yue Li, Dan Jiang
<p><strong>Background: </strong>Scant data are available on heterogenous staining of mismatch repair protein in colorectal cancer.</p><p><strong>Objective: </strong>This study aimed to improve insights into clinicopathologic features and prognosis of colorectal cancer harboring heterogenous mismatch repair protein staining.</p><p><strong>Design: </strong>A single-center retrospective observational study.</p><p><strong>Setting: </strong>This study was conducted in a tertiary referral center in China between 2014 and 2018.</p><p><strong>Patients: </strong>Patients with colorectal cancers with heterogenous staining of mismatch repair protein were included.</p><p><strong>Main outcome measures: </strong>Clinicopathologic and molecular features and survival outcomes were analyzed.</p><p><strong>Results: </strong>A total of 151 of 6721 colorectal cancers (2.2%) exhibited heterogenous staining for at least 1 mismatch repair protein, with intraglandular heterogeneity being the most common pattern (89.4%). Heterogenous mutL homolog 1 staining was significantly associated with distant metastasis ( p = 0.03), whereas heterogenous mutS homolog 2 staining was associated with left-sided ( p = 0.03) and earlier pT stage tumors ( p = 0.02). The rates of microsatellite instability-high, K -ras and BRAF mutation were 12.6%, 47.3%, and 3.4%, respectively. Microsatellite instability-high was significantly associated with higher intraglandular mutS homolog 6 heterogeneity frequency ( p < 0.001) and decreased mutS homolog 6 expression level (<27.5%, p = 0.01). BRAF mutation was associated with the coexistence of intraglandular and clonal heterogeneity ( p = 0.003) and decreased PMS1 homolog 2 expression level ( p = 0.01). Multivariable analysis revealed that progression-free survival was significantly associated with tumor stage ( p = 0.003), stroma fraction ( p = 0.004), and heterogenous PMS1 homolog 2 staining ( p = 0.02). Overall survival was linked to tumor stage ( p = 0.006) and BRAF mutation ( p = 0.01).</p><p><strong>Limitations: </strong>The limitations of this study include the absence of testing for mutL homolog 1 promoter methylation and mismatch repair gene mutations, its retrospective design, and insufficient data related to direct comparison with deficient mismatch repair and proficient mismatch repair colorectal cancer.</p><p><strong>Conclusions: </strong>Heterogenous mismatch repair protein staining in colorectal cancer exhibits distinct associations with tumor location, stage, microsatellite instability, BRAF mutation, and prognosis. It is recommended to report mutS homolog 6 heterogeneity as it may indicate microsatellite instability-high. See Video Abstract .</p><p><strong>Resultados y caractersticas clnicopatolgicas en la tincin heterognea de protenas reparadoras de error de emparejamiento en casos de cncer colorrectal: </strong>ANTECEDENTES:Son pocos los datos disponibles sobre la tinción heterogénea de la proteína reparadora de errores de empareja
背景:关于结直肠癌错配修复蛋白异源染色的数据很少:本研究旨在提高对带有异源性错配修复蛋白染色的结直肠癌的临床病理特征和预后的认识:单中心回顾性观察研究:本研究于2014年至2018年在中国的一家三级转诊中心进行:主要结果指标:分析临床病理和分子特征以及生存结果:在6721例结直肠癌中,共有151例(2.2%)至少一种错配修复蛋白出现异质性染色,其中腺内异质性是最常见的模式(89.4%)。异源性MLH1染色与远处转移显著相关(p = 0.03),而异源性MSH2染色与左侧(p = 0.03)和pT分期较早的肿瘤相关(p = 0.02)。微卫星不稳定性高、KRAS和BRAF突变率分别为12.6%、47.3%和3.4%。微卫星不稳定性高与较高的腺内 MSH6 异质性频率(p < 0.001)和 MSH6 表达水平下降(< 27.5%,p = 0.01)显著相关。BRAF突变与腺内异质性和克隆异质性并存(p = 0.003)和PMS2表达水平下降(p = 0.01)相关。多变量分析显示,无进展生存期与肿瘤分期(p = 0.003)、基质部分(p = 0.004)和异质性 PMS2 染色(p = 0.02)显著相关。总生存率与肿瘤分期(p = 0.006)和BRAF突变(p = 0.01)有关:本研究的局限性包括:未检测 MLH1 启动子甲基化和错配修复基因突变,研究为回顾性设计,与错配修复缺陷型和错配修复熟练型结直肠癌直接比较的相关数据不足:结论:结直肠癌中的异源性错配修复蛋白染色与肿瘤位置、分期、微卫星不稳定性、BRAF突变和预后有明显的关联。建议报告MSH6异质性,因为它可能预示着微卫星不稳定性高。参见视频摘要。
{"title":"Clinicopathological Characteristics and Outcomes of Colorectal Cancer With Heterogenous Staining of Mismatch Repair Protein.","authors":"Xian Zhang, Yu-Jue Wang, Lin-Yong Sun, Yin-Xia Tu, Yue Li, Dan Jiang","doi":"10.1097/DCR.0000000000003527","DOIUrl":"10.1097/DCR.0000000000003527","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Scant data are available on heterogenous staining of mismatch repair protein in colorectal cancer.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aimed to improve insights into clinicopathologic features and prognosis of colorectal cancer harboring heterogenous mismatch repair protein staining.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;A single-center retrospective observational study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Setting: &lt;/strong&gt;This study was conducted in a tertiary referral center in China between 2014 and 2018.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patients: &lt;/strong&gt;Patients with colorectal cancers with heterogenous staining of mismatch repair protein were included.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcome measures: &lt;/strong&gt;Clinicopathologic and molecular features and survival outcomes were analyzed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 151 of 6721 colorectal cancers (2.2%) exhibited heterogenous staining for at least 1 mismatch repair protein, with intraglandular heterogeneity being the most common pattern (89.4%). Heterogenous mutL homolog 1 staining was significantly associated with distant metastasis ( p = 0.03), whereas heterogenous mutS homolog 2 staining was associated with left-sided ( p = 0.03) and earlier pT stage tumors ( p = 0.02). The rates of microsatellite instability-high, K -ras and BRAF mutation were 12.6%, 47.3%, and 3.4%, respectively. Microsatellite instability-high was significantly associated with higher intraglandular mutS homolog 6 heterogeneity frequency ( p &lt; 0.001) and decreased mutS homolog 6 expression level (&lt;27.5%, p = 0.01). BRAF mutation was associated with the coexistence of intraglandular and clonal heterogeneity ( p = 0.003) and decreased PMS1 homolog 2 expression level ( p = 0.01). Multivariable analysis revealed that progression-free survival was significantly associated with tumor stage ( p = 0.003), stroma fraction ( p = 0.004), and heterogenous PMS1 homolog 2 staining ( p = 0.02). Overall survival was linked to tumor stage ( p = 0.006) and BRAF mutation ( p = 0.01).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;The limitations of this study include the absence of testing for mutL homolog 1 promoter methylation and mismatch repair gene mutations, its retrospective design, and insufficient data related to direct comparison with deficient mismatch repair and proficient mismatch repair colorectal cancer.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Heterogenous mismatch repair protein staining in colorectal cancer exhibits distinct associations with tumor location, stage, microsatellite instability, BRAF mutation, and prognosis. It is recommended to report mutS homolog 6 heterogeneity as it may indicate microsatellite instability-high. See Video Abstract .&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Resultados y caractersticas clnicopatolgicas en la tincin heterognea de protenas reparadoras de error de emparejamiento en casos de cncer colorrectal: &lt;/strong&gt;ANTECEDENTES:Son pocos los datos disponibles sobre la tinción heterogénea de la proteína reparadora de errores de empareja","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":"48-59"},"PeriodicalIF":3.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142343664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expert Commentary on Diagnosis and Management of Anal Stenosis. 肛门狭窄的诊断和治疗专家评论。
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-17 DOI: 10.1097/DCR.0000000000003556
Ugo Grossi
{"title":"Expert Commentary on Diagnosis and Management of Anal Stenosis.","authors":"Ugo Grossi","doi":"10.1097/DCR.0000000000003556","DOIUrl":"10.1097/DCR.0000000000003556","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":"68 1","pages":"12-13"},"PeriodicalIF":3.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649172/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142827846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Loop Ileostomy Reversal. 环形回肠造口术逆转术
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-22 DOI: 10.1097/DCR.0000000000003441
Inthat Boonpongmanee, Luay D Ailabouni
{"title":"Loop Ileostomy Reversal.","authors":"Inthat Boonpongmanee, Luay D Ailabouni","doi":"10.1097/DCR.0000000000003441","DOIUrl":"10.1097/DCR.0000000000003441","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":"e1-e2"},"PeriodicalIF":3.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142460454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expert Commentary on Endoscopic and Transanal Management of Anastomotic Leak. 内镜及经肛治疗吻合口瘘的专家评论。
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-12-31 DOI: 10.1097/DCR.0000000000003626
Roel Hompes
{"title":"Expert Commentary on Endoscopic and Transanal Management of Anastomotic Leak.","authors":"Roel Hompes","doi":"10.1097/DCR.0000000000003626","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003626","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142946489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic Complete Mesocolic Excision-Central Vascular Ligation: Bottom to Up Approach. 机器人完成肠系膜切除-中央血管结扎:自下而上的方法。
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-12-31 DOI: 10.1097/DCR.0000000000003539
Nishtha Midha, Syed Althaf, Pavan Sugoor
{"title":"Robotic Complete Mesocolic Excision-Central Vascular Ligation: Bottom to Up Approach.","authors":"Nishtha Midha, Syed Althaf, Pavan Sugoor","doi":"10.1097/DCR.0000000000003539","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003539","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142946491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deloyers Technique for Restoration of Bowel Continuity Following Extended Left Hemicolectomy: A Comprehensive Analysis of 97 Cases and Literature Review. 左半结肠切除术后恢复肠连续性的Deloyers技术:97例综合分析并文献复习。
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-12-30 DOI: 10.1097/DCR.0000000000003597
Lucas F Sobrado, Lukas Schabl, Niamh M Foley, Christopher Prien, Sergio C Nahas, David Liska, Hermann Kessler, Michael A Valente, Scott R Steele, Tracy L Hull

Background: Deloyers technique addresses challenges in restoring bowel continuity following extended left hemicolectomies. Despite being first described in 1958, the technique remains underutilized, with limited data on long-term outcomes.

Objective: To evaluate the indications, surgical and functional outcomes of Deloyers technique and review existing literature.

Design: Using a prospectively maintained database, patient demographics and perioperative data were collected. A telephone interview was conducted to assess bowel function and statistical analysis identified factors affecting bowel function.

Settings: Single tertiary care center.

Patients: Patients that underwent Deloyers technique from January 1995 to February 2023.

Results: A total of 97 patients were included. Most common indications were colorectal cancer (50.5%) and diverticular disease (21.6%). In 53.6% of cases DT was performed at re-operations and in 70.1% a diverting loop ileostomy was created. Early surgical complications occurred in 7.2% of patients, including five anastomotic leaks, one colonic conduit ischemia and one small bowel obstruction. Late complications occurred in 8.2%, including 6 anastomotic strictures and 2 chronic leaks. There was no perioperative mortality. A total of 40 patients were interviewed and reported an average of 3.5 bowel movements per day and 0.5 at night, 17.5% used bowel stoppers and 52.5% of patients reported that their bowel function did not impact their quality of life. Previous radiotherapy and anastomosis less than eight cm from the anal verge were associated with having four or more bowel movements per day (p < 0.01).

Main outcomes measures: Postoperative morbidity and bowel function.

Limitations: Retrospective analysis of a heterogeneous group of patients with different pathologies and indications for surgery.

Conclusion: Deloyers technique is a safe and effective alternative for restoring bowel continuity after extended left hemicolectomy. Postoperative functional results are generally satisfactory, with more favorable outcomes noted in patients with higher anastomoses and those who have not undergone prior pelvic radiotherapy.

背景:Deloyers技术解决了延长左半结肠切除术后恢复肠道连续性的挑战。尽管该技术于1958年首次被描述,但仍未得到充分利用,长期结果的数据有限。目的:评价Deloyers技术的适应证、手术及功能效果,并对已有文献进行复习。设计:使用前瞻性维护的数据库,收集患者人口统计学和围手术期数据。通过电话访谈评估肠功能,并通过统计分析确定影响肠功能的因素。设置:单一三级保健中心。患者:1995年1月至2023年2月行Deloyers技术的患者。结果:共纳入97例患者。最常见的适应症是结直肠癌(50.5%)和憩室病(21.6%)。53.6%的病例在再次手术时进行了DT, 70.1%的病例建立了转移袢回肠造口。7.2%的患者出现手术早期并发症,包括吻合口瘘5例,结肠导管缺血1例,小肠梗阻1例。晚期并发症发生率8.2%,其中吻合口狭窄6例,慢性瘘2例。无围手术期死亡。共采访了40名患者,报告平均每天排便3.5次,夜间排便0.5次,17.5%的患者使用肠塞,52.5%的患者报告他们的排便功能不影响他们的生活质量。既往放疗及吻合术距肛缘小于8cm者,每日排便次数为4次或以上(p < 0.01)。主要观察指标:术后发病率和肠功能。局限性:回顾性分析了一组不同病理和手术指征的患者。结论:Deloyers技术是延长左结肠切除术后恢复肠道连续性的一种安全有效的方法。术后功能结果一般令人满意,吻合口较高的患者和未接受盆腔放疗的患者预后更佳。
{"title":"Deloyers Technique for Restoration of Bowel Continuity Following Extended Left Hemicolectomy: A Comprehensive Analysis of 97 Cases and Literature Review.","authors":"Lucas F Sobrado, Lukas Schabl, Niamh M Foley, Christopher Prien, Sergio C Nahas, David Liska, Hermann Kessler, Michael A Valente, Scott R Steele, Tracy L Hull","doi":"10.1097/DCR.0000000000003597","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003597","url":null,"abstract":"<p><strong>Background: </strong>Deloyers technique addresses challenges in restoring bowel continuity following extended left hemicolectomies. Despite being first described in 1958, the technique remains underutilized, with limited data on long-term outcomes.</p><p><strong>Objective: </strong>To evaluate the indications, surgical and functional outcomes of Deloyers technique and review existing literature.</p><p><strong>Design: </strong>Using a prospectively maintained database, patient demographics and perioperative data were collected. A telephone interview was conducted to assess bowel function and statistical analysis identified factors affecting bowel function.</p><p><strong>Settings: </strong>Single tertiary care center.</p><p><strong>Patients: </strong>Patients that underwent Deloyers technique from January 1995 to February 2023.</p><p><strong>Results: </strong>A total of 97 patients were included. Most common indications were colorectal cancer (50.5%) and diverticular disease (21.6%). In 53.6% of cases DT was performed at re-operations and in 70.1% a diverting loop ileostomy was created. Early surgical complications occurred in 7.2% of patients, including five anastomotic leaks, one colonic conduit ischemia and one small bowel obstruction. Late complications occurred in 8.2%, including 6 anastomotic strictures and 2 chronic leaks. There was no perioperative mortality. A total of 40 patients were interviewed and reported an average of 3.5 bowel movements per day and 0.5 at night, 17.5% used bowel stoppers and 52.5% of patients reported that their bowel function did not impact their quality of life. Previous radiotherapy and anastomosis less than eight cm from the anal verge were associated with having four or more bowel movements per day (p < 0.01).</p><p><strong>Main outcomes measures: </strong>Postoperative morbidity and bowel function.</p><p><strong>Limitations: </strong>Retrospective analysis of a heterogeneous group of patients with different pathologies and indications for surgery.</p><p><strong>Conclusion: </strong>Deloyers technique is a safe and effective alternative for restoring bowel continuity after extended left hemicolectomy. Postoperative functional results are generally satisfactory, with more favorable outcomes noted in patients with higher anastomoses and those who have not undergone prior pelvic radiotherapy.</p>","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142946487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oligometastatic Disease Is Not an Absolute Contraindication to Pelvic Exenteration in Selected Patients With Locally Recurrent Rectal Cancer. 少数转移性疾病并非局部复发直肠癌患者盆腔切除术的绝对禁忌症。
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-12-27 DOI: 10.1097/DCR.0000000000003613
Jennifer K Vu, Kilian G M Brown, Michael J Solomon, Kheng-Seong Ng, Kate Mahon, Bernard K Le, Sarah Sutherland, Peter J Lee, Christopher M Byrne, Kirk K S Austin, Daniel Steffens

Background: The treatment of locally recurrent rectal cancer has evolved dramatically in recent decades. As the boundaries of exenterative surgery continue to be pushed, one of the unanswered and controversial questions is the role of radical salvage surgery for locally recurrent rectal cancer in the setting of oligometastatic disease.

Objective: To investigate the impact of synchronous or previously treated distant metastases on survival following pelvic exenteration for locally recurrent rectal cancer.

Design: Retrospective analysis of a prospectively maintained database.

Settings: A high-volume specialist exenteration center.

Patients: Consecutive adult patients undergoing pelvic exenteration with curative intent for locally recurrent rectal cancer between 1994 and 2023.

Main outcome measures: Overall survival from time of pelvic exenteration.

Results: Of the 300 patients included, 193 (64%) were male and the median age was 62 years (range, 29-86). Median time from primary rectal cancer surgery to pelvic exenteration was 35 months (range, 4-191). In total, 56 patients (19%) had a history of metastatic disease; of which 42 (14%) had previously treated metastases and 18 patients (6%) had synchronous metastatic disease (including 4 patients with both synchronous and previously treated metastases). Five-year and median overall survival was 41% and 45 months, respectively. There was a trend toward poorer 5-year overall survival in patients with a history of metastatic disease compared to those without (25% vs 45%); however, this did not reach statistical significance (p = 0.110), possibly due to lack of statistical power. Five-year overall survival was 27%, 25% and 45% for patients with synchronous metastases, previously treated metastases, and no history of metastases, respectively (p = 0.260).

Limitations: Findings may not be applicable beyond highly selected patients treated at specialized exenteration centers.

Conclusions: Long-term survival is achievable in highly selected patients with locally recurrent rectal cancer and synchronous or previously treated distant metastases. Therefore, oligometastatic disease should not be considered an absolute contraindication to exenterative surgery. See Video Abstract.

背景:近几十年来,局部复发性直肠癌的治疗发生了巨大的变化。随着切除手术的界限不断被推进,其中一个悬而未决的和有争议的问题是根治性挽救性手术治疗局部复发直肠癌在低转移性疾病中的作用。目的:探讨同步或既往治疗过的远处转移对局部复发直肠癌盆腔切除术后生存率的影响。设计:对前瞻性维护数据库进行回顾性分析。设置:一个高容量的专家切除中心。患者:1994年至2023年间连续接受盆腔切除术治疗局部复发性直肠癌的成年患者。主要观察指标:盆腔切除后的总生存率。结果:纳入的300例患者中,男性193例(64%),中位年龄62岁(29-86岁)。从原发性直肠癌手术到盆腔切除的中位时间为35个月(范围4-191)。总共56例患者(19%)有转移性疾病史;其中42例(14%)曾接受过转移治疗,18例(6%)患有同步转移性疾病(包括4例同时接受过转移治疗和同步转移的患者)。5年和中位总生存期分别为41%和45个月。与无转移病史的患者相比,有转移病史患者的5年总生存率有较差的趋势(25% vs 45%);然而,这并没有达到统计学意义(p = 0.110),可能是由于缺乏统计能力。同步转移患者、既往治疗过的转移患者和无转移史患者的5年总生存率分别为27%、25%和45% (p = 0.260)。局限性:研究结果可能不适用于在专业拔牙中心治疗的高度选定的患者。结论:高度选择性的局部复发直肠癌和同步或既往治疗过的远处转移患者可以实现长期生存。因此,少转移性疾病不应被视为绝对禁忌症。参见视频摘要。
{"title":"Oligometastatic Disease Is Not an Absolute Contraindication to Pelvic Exenteration in Selected Patients With Locally Recurrent Rectal Cancer.","authors":"Jennifer K Vu, Kilian G M Brown, Michael J Solomon, Kheng-Seong Ng, Kate Mahon, Bernard K Le, Sarah Sutherland, Peter J Lee, Christopher M Byrne, Kirk K S Austin, Daniel Steffens","doi":"10.1097/DCR.0000000000003613","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003613","url":null,"abstract":"<p><strong>Background: </strong>The treatment of locally recurrent rectal cancer has evolved dramatically in recent decades. As the boundaries of exenterative surgery continue to be pushed, one of the unanswered and controversial questions is the role of radical salvage surgery for locally recurrent rectal cancer in the setting of oligometastatic disease.</p><p><strong>Objective: </strong>To investigate the impact of synchronous or previously treated distant metastases on survival following pelvic exenteration for locally recurrent rectal cancer.</p><p><strong>Design: </strong>Retrospective analysis of a prospectively maintained database.</p><p><strong>Settings: </strong>A high-volume specialist exenteration center.</p><p><strong>Patients: </strong>Consecutive adult patients undergoing pelvic exenteration with curative intent for locally recurrent rectal cancer between 1994 and 2023.</p><p><strong>Main outcome measures: </strong>Overall survival from time of pelvic exenteration.</p><p><strong>Results: </strong>Of the 300 patients included, 193 (64%) were male and the median age was 62 years (range, 29-86). Median time from primary rectal cancer surgery to pelvic exenteration was 35 months (range, 4-191). In total, 56 patients (19%) had a history of metastatic disease; of which 42 (14%) had previously treated metastases and 18 patients (6%) had synchronous metastatic disease (including 4 patients with both synchronous and previously treated metastases). Five-year and median overall survival was 41% and 45 months, respectively. There was a trend toward poorer 5-year overall survival in patients with a history of metastatic disease compared to those without (25% vs 45%); however, this did not reach statistical significance (p = 0.110), possibly due to lack of statistical power. Five-year overall survival was 27%, 25% and 45% for patients with synchronous metastases, previously treated metastases, and no history of metastases, respectively (p = 0.260).</p><p><strong>Limitations: </strong>Findings may not be applicable beyond highly selected patients treated at specialized exenteration centers.</p><p><strong>Conclusions: </strong>Long-term survival is achievable in highly selected patients with locally recurrent rectal cancer and synchronous or previously treated distant metastases. Therefore, oligometastatic disease should not be considered an absolute contraindication to exenterative surgery. See Video Abstract.</p>","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142892485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Audit of a Novel Nurse-Led Program for Non-Antibiotic Management of Acute Uncomplicated Diverticulitis. 一种新型护士主导的急性无并发症憩室炎非抗生素治疗方案的审核。
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-12-27 DOI: 10.1097/DCR.0000000000003612
Huseen Alibrahim, Jessica Pinto, Sarah Sabboobeh, Neyla Boukhili, Marie Demian, Carol-Ann Vasilevsky, Marylise Boutros

Background: Non-antibiotic outpatient treatment of acute uncomplicated diverticulitis is safe; however, uptake remains low.

Objective: To assess the success of non-antibiotic management of uncomplicated diverticulitis through a nurse clinician-led outpatient program.

Design: Retrospective audit from June 2022-March 2024.

Settings: Nurse clinician-led outpatient program for non-antibiotic management of acute uncomplicated diverticulitis at a university-affiliated hospital.

Patients: Immunocompetent adults with CT-proven acute uncomplicated diverticulitis and C-reactive protein <150 mg/L. Eligible patients not referred to the program but treated in the Emergency Department during the same time period were also reviewed.

Interventions: This program included education, diet modification, analgesia, clinic visit, and telephone follow-ups by a nurse-clinician.

Main outcome measures: Primary outcome was success of the program, defined as the proportion not requiring an Emergency Department visit, admissions within 60 days of diagnosis or need for antibiotics.

Results: Of 236 patients referred to the program, 84 met inclusion criteria, of which 43 (51.2%) were started on antibiotics before referral but were treated by the program. Forty-one (48.8%) completed the non-antibiotic protocol (48.8%, n = 41), with 97.6% success. Concurrently, 219 eligible patients were treated in the Emergency Department but not referred to the program. There was no difference in the number of Emergency Department visits between the 2 groups [program: n = 7 (8.3%) vs Emergency Department: n = 27 (12.3%)] within 60 days of diagnosis. Two patients (2.3%) treated in the program required admission, while 7 (3.2%) patients in the Emergency Department group were admitted. Overall, antibiotics were started before referral in 51.2% of patients in the program compared to 92.2% in the Emergency Department (p < 0.005).

Limitations: Modest sample size, single institutional data and retrospective design.

Conclusions: Implementation of non-antibiotic treatment for mild acute uncomplicated diverticulitis can be successful using an outpatient nurse-clinician led program with referrals from the Emergency Department and community. See Video Abstract.

背景:非抗生素门诊治疗急性无并发症憩室炎是安全的;然而,吸收率仍然很低。目的:通过护士临床医生主导的门诊项目评估非抗生素治疗非并发症憩室炎的成功。设计:2022年6月- 2024年3月回顾性审核。背景:在一所大学附属医院,护士临床医生主导的非抗生素治疗急性无并发症憩室炎门诊项目。患者:经ct证实的具有免疫功能的成人急性无并发症憩室炎和c反应蛋白干预:该项目包括教育、饮食调整、镇痛、门诊就诊和护士-临床医生的电话随访。主要结局指标:主要结局指标是项目的成功,定义为不需要急诊科就诊的比例,诊断后60天内入院或需要抗生素。结果:236例患者中,84例符合纳入标准,其中43例(51.2%)在转诊前开始使用抗生素,但接受了该计划的治疗。41例(48.8%)完成了非抗生素方案(48.8%,n = 41),成功率为97.6%。同时,219名符合条件的患者在急诊科接受治疗,但未转介到该计划。两组患者在诊断后60天内急诊科就诊次数无差异[方案:n = 7 (8.3%) vs急诊科:n = 27(12.3%)]。该方案治疗的2例患者(2.3%)需要入院,而急诊科组的7例患者(3.2%)入院。总体而言,51.2%的患者在转诊前开始使用抗生素,而急诊科的这一比例为92.2% (p < 0.005)。局限性:样本量适中,单一机构数据和回顾性设计。结论:采用门诊护士-临床医生主导的方案,结合急诊科和社区的转诊,对轻度急性无并发症憩室炎实施非抗生素治疗是成功的。参见视频摘要。
{"title":"Audit of a Novel Nurse-Led Program for Non-Antibiotic Management of Acute Uncomplicated Diverticulitis.","authors":"Huseen Alibrahim, Jessica Pinto, Sarah Sabboobeh, Neyla Boukhili, Marie Demian, Carol-Ann Vasilevsky, Marylise Boutros","doi":"10.1097/DCR.0000000000003612","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003612","url":null,"abstract":"<p><strong>Background: </strong>Non-antibiotic outpatient treatment of acute uncomplicated diverticulitis is safe; however, uptake remains low.</p><p><strong>Objective: </strong>To assess the success of non-antibiotic management of uncomplicated diverticulitis through a nurse clinician-led outpatient program.</p><p><strong>Design: </strong>Retrospective audit from June 2022-March 2024.</p><p><strong>Settings: </strong>Nurse clinician-led outpatient program for non-antibiotic management of acute uncomplicated diverticulitis at a university-affiliated hospital.</p><p><strong>Patients: </strong>Immunocompetent adults with CT-proven acute uncomplicated diverticulitis and C-reactive protein <150 mg/L. Eligible patients not referred to the program but treated in the Emergency Department during the same time period were also reviewed.</p><p><strong>Interventions: </strong>This program included education, diet modification, analgesia, clinic visit, and telephone follow-ups by a nurse-clinician.</p><p><strong>Main outcome measures: </strong>Primary outcome was success of the program, defined as the proportion not requiring an Emergency Department visit, admissions within 60 days of diagnosis or need for antibiotics.</p><p><strong>Results: </strong>Of 236 patients referred to the program, 84 met inclusion criteria, of which 43 (51.2%) were started on antibiotics before referral but were treated by the program. Forty-one (48.8%) completed the non-antibiotic protocol (48.8%, n = 41), with 97.6% success. Concurrently, 219 eligible patients were treated in the Emergency Department but not referred to the program. There was no difference in the number of Emergency Department visits between the 2 groups [program: n = 7 (8.3%) vs Emergency Department: n = 27 (12.3%)] within 60 days of diagnosis. Two patients (2.3%) treated in the program required admission, while 7 (3.2%) patients in the Emergency Department group were admitted. Overall, antibiotics were started before referral in 51.2% of patients in the program compared to 92.2% in the Emergency Department (p < 0.005).</p><p><strong>Limitations: </strong>Modest sample size, single institutional data and retrospective design.</p><p><strong>Conclusions: </strong>Implementation of non-antibiotic treatment for mild acute uncomplicated diverticulitis can be successful using an outpatient nurse-clinician led program with referrals from the Emergency Department and community. See Video Abstract.</p>","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142892968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guideline Concordant Extended Pharmacologic Venous Thromboembolism Prophylaxis Utilization After Colorectal Cancer Resection Is Low Regardless of Patient Factors or Hospital Characteristics. 指南:无论患者因素或医院特点如何,结直肠癌切除术后扩展药物静脉血栓栓塞预防使用率都很低。
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-12-27 DOI: 10.1097/DCR.0000000000003616
Colleen Donahue, Daniel Brinton, Alexander Booth, Maggie Westfal, Virgilio George, Pinckney Johnstone Maxwell, Kit Simpson, Thomas Curran

Background: Venous thromboembolism after colorectal cancer resection is common and highly morbid. Extended pharmacologic venous thromboembolism prophylaxis after cancer surgery lowers venous thromboembolism risk and is recommended by major professional societies. Adherence is low in contemporary local and regional studies.

Objective: Assess patient and hospital factors associated with receipt of prophylaxis after colorectal cancer surgery in a national data set.

Design: Retrospective cohort study.

Settings: Surveillance, epidemiology, and end results Medicare dataset.

Patients: Patients over age 64 undergoing resection for colorectal cancer between 2016 and 2017.

Main outcome measures: Primary outcome was receipt of prophylaxis within 7 days of discharge. Patient and hospital factors associated with receiving prophylaxis were identified using multivariable logistic regression. Secondary outcomes included 30- and 90-day venous thromboembolism.

Results: Of 23,527 patients, 4.7% received prophylaxis. Utilization increased from 2016 to 2017 (3.9% vs. 5.5%; p < 0.001). Patients treated at National Cancer Institute designated hospitals received prophylaxis more frequently than teaching, non-National Cancer Institute hospitals and non-teaching, non-National Cancer Institute hospitals (10.2% vs. 5.6% vs. 1.7%; p < 0.001). Patients receiving care at larger hospitals by bed size quartile were more likely to receive prophylaxis compared to those at smaller hospitals (9.0% vs. 4.0% vs. 3.4% vs. 2.2%; p < 0.01). On multivariable regression, National Cancer Institute status, larger bed size, White race (compared to other), rectal tumor location and more recent year of treatment were independently associated with prophylaxis utilization. Venous thromboembolism events at 30- and 90-days were 1.87% and 2.63%, respectively. Prophylaxis was associated with decreased 30-day venous thromboembolism (1.26% vs. 1.9%; p = 0.1211).

Limitations: Retrospective, large database study.

Conclusions: Utilization of prophylaxis after colorectal cancer surgery remains limited even in large, specialized hospitals. Further work is needed to understand this departure from guideline concordant care. See Video Abstract.

背景:结直肠癌术后静脉血栓栓塞是一种常见且高发病率的疾病。癌症手术后延长药物静脉血栓栓塞预防可降低静脉血栓栓塞的风险,并被主要专业协会推荐。在当代的地方和区域研究中,依从性较低。目的:在全国数据集中评估与结直肠癌手术后接受预防相关的患者和医院因素。设计:回顾性队列研究。设置:监测、流行病学和最终结果医疗保险数据集。患者:2016年至2017年期间接受结直肠癌切除术的64岁以上患者。主要结局指标:主要结局指标为出院后7天内接受预防治疗。使用多变量logistic回归确定与接受预防相关的患者和医院因素。次要结局包括30天和90天静脉血栓栓塞。结果:23,527例患者中,4.7%接受了预防。利用率从2016年到2017年有所增加(3.9%对5.5%;P < 0.001)。在国家癌症研究所指定医院接受治疗的患者接受预防治疗的频率高于教学、非国家癌症研究所医院和非教学、非国家癌症研究所医院(10.2%对5.6%对1.7%;P < 0.001)。按床位大小四分位数划分,在大医院接受治疗的患者比在小医院接受治疗的患者更有可能接受预防(9.0% vs. 4.0% vs. 3.4% vs. 2.2%;P < 0.01)。在多变量回归中,国家癌症研究所的地位、更大的床位、白人种族(与其他种族相比)、直肠肿瘤位置和最近治疗年份与预防使用独立相关。30天和90天静脉血栓栓塞事件分别为1.87%和2.63%。预防与减少30天静脉血栓栓塞相关(1.26% vs 1.9%;P = 0.1211)。局限性:回顾性、大型数据库研究。结论:即使在大型专科医院,结直肠癌手术后预防措施的应用仍然有限。需要进一步的工作来理解这种偏离指南的一致性护理。参见视频摘要。
{"title":"Guideline Concordant Extended Pharmacologic Venous Thromboembolism Prophylaxis Utilization After Colorectal Cancer Resection Is Low Regardless of Patient Factors or Hospital Characteristics.","authors":"Colleen Donahue, Daniel Brinton, Alexander Booth, Maggie Westfal, Virgilio George, Pinckney Johnstone Maxwell, Kit Simpson, Thomas Curran","doi":"10.1097/DCR.0000000000003616","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003616","url":null,"abstract":"<p><strong>Background: </strong>Venous thromboembolism after colorectal cancer resection is common and highly morbid. Extended pharmacologic venous thromboembolism prophylaxis after cancer surgery lowers venous thromboembolism risk and is recommended by major professional societies. Adherence is low in contemporary local and regional studies.</p><p><strong>Objective: </strong>Assess patient and hospital factors associated with receipt of prophylaxis after colorectal cancer surgery in a national data set.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Settings: </strong>Surveillance, epidemiology, and end results Medicare dataset.</p><p><strong>Patients: </strong>Patients over age 64 undergoing resection for colorectal cancer between 2016 and 2017.</p><p><strong>Main outcome measures: </strong>Primary outcome was receipt of prophylaxis within 7 days of discharge. Patient and hospital factors associated with receiving prophylaxis were identified using multivariable logistic regression. Secondary outcomes included 30- and 90-day venous thromboembolism.</p><p><strong>Results: </strong>Of 23,527 patients, 4.7% received prophylaxis. Utilization increased from 2016 to 2017 (3.9% vs. 5.5%; p < 0.001). Patients treated at National Cancer Institute designated hospitals received prophylaxis more frequently than teaching, non-National Cancer Institute hospitals and non-teaching, non-National Cancer Institute hospitals (10.2% vs. 5.6% vs. 1.7%; p < 0.001). Patients receiving care at larger hospitals by bed size quartile were more likely to receive prophylaxis compared to those at smaller hospitals (9.0% vs. 4.0% vs. 3.4% vs. 2.2%; p < 0.01). On multivariable regression, National Cancer Institute status, larger bed size, White race (compared to other), rectal tumor location and more recent year of treatment were independently associated with prophylaxis utilization. Venous thromboembolism events at 30- and 90-days were 1.87% and 2.63%, respectively. Prophylaxis was associated with decreased 30-day venous thromboembolism (1.26% vs. 1.9%; p = 0.1211).</p><p><strong>Limitations: </strong>Retrospective, large database study.</p><p><strong>Conclusions: </strong>Utilization of prophylaxis after colorectal cancer surgery remains limited even in large, specialized hospitals. Further work is needed to understand this departure from guideline concordant care. See Video Abstract.</p>","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142892969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence Recognition System of Pelvic Autonomic Nerve During Total Mesorectal Excision. 全肠系膜切除术中盆腔自主神经的人工智能识别系统。
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-12-23 DOI: 10.1097/DCR.0000000000003547
Fanghai Han, Guangyu Zhong, Shilin Zhi, Naiqian Han, Yongjun Jiang, Jia'nan Tan, Lin Zhong, Shengning Zhou

Background: The preservation of the pelvic autonomic nervous system in total mesorectal excision remains challenging to date. The application of laparoscopy has enabled visualization of fine anatomical structures; however, the rate of urogenital dysfunction remains high.

Objective: To establish an artificial intelligence neurorecognition system to perform neurorecognition during total mesorectal excision.

Design: This retrospective study.

Setting: The study was conducted at a single hospital.

Patients: Intraoperative images or video screenshots of rectal cancer patients admitted to the Department of Gastrointestinal Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, between January 2016 and December 2023 were retrospectively collected.

Main outcome measure: Mean intersection over union, precision, recall, and F1 of the model.

Results: A total of 1424 high-quality intraoperative images were included in the training group. The proposed model was obtained after 700 iterations. The mean intersection over union was 0.75, and it slowly increased with an increase in training time. The precision and recall of the nerve category were 0.7494 and 0.6587, respectively, and the F1 was 0.7011. From the video prediction, we can observe that the model achieves a high accuracy rate, which could facilitate effective neurorecognition.

Limitation: This was a single-center study.

Conclusion: The artificial intelligence model for real-time visual neurorecognition in total mesorectal excision was successfully established for the first time in China. Better identification of these autonomic nerves should allow for better preservation of urogenital function, but further research is needed to validate this claim. See Video Abstract.

背景:盆腔自主神经系统的保存在全肠系膜切除术至今仍然具有挑战性。腹腔镜的应用使精细解剖结构可视化;然而,泌尿生殖功能障碍的发生率仍然很高。目的:建立人工智能神经识别系统,在全肠系膜切除术中进行神经识别。设计:回顾性研究。环境:本研究在一家医院进行。患者:回顾性收集2016年1月至2023年12月中山大学孙逸仙纪念医院胃肠外科收治的直肠癌患者术中图像或视频截图。主要结果测量:模型的联合、精度、召回率和F1的平均交集。结果:训练组共获得高质量术中图像1424张。经过700次迭代得到了该模型。与并集的平均交点为0.75,随训练时间的增加而缓慢增加。神经分类的查准率和查全率分别为0.7494和0.6587,F1为0.7011。从视频预测中可以看出,该模型达到了较高的准确率,可以进行有效的神经识别。局限性:这是一项单中心研究。结论:国内首次成功建立全肠系膜切除术实时视觉神经识别人工智能模型。更好地识别这些自主神经应该允许更好地保存泌尿生殖功能,但需要进一步的研究来验证这一说法。参见视频摘要。
{"title":"Artificial Intelligence Recognition System of Pelvic Autonomic Nerve During Total Mesorectal Excision.","authors":"Fanghai Han, Guangyu Zhong, Shilin Zhi, Naiqian Han, Yongjun Jiang, Jia'nan Tan, Lin Zhong, Shengning Zhou","doi":"10.1097/DCR.0000000000003547","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003547","url":null,"abstract":"<p><strong>Background: </strong>The preservation of the pelvic autonomic nervous system in total mesorectal excision remains challenging to date. The application of laparoscopy has enabled visualization of fine anatomical structures; however, the rate of urogenital dysfunction remains high.</p><p><strong>Objective: </strong>To establish an artificial intelligence neurorecognition system to perform neurorecognition during total mesorectal excision.</p><p><strong>Design: </strong>This retrospective study.</p><p><strong>Setting: </strong>The study was conducted at a single hospital.</p><p><strong>Patients: </strong>Intraoperative images or video screenshots of rectal cancer patients admitted to the Department of Gastrointestinal Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, between January 2016 and December 2023 were retrospectively collected.</p><p><strong>Main outcome measure: </strong>Mean intersection over union, precision, recall, and F1 of the model.</p><p><strong>Results: </strong>A total of 1424 high-quality intraoperative images were included in the training group. The proposed model was obtained after 700 iterations. The mean intersection over union was 0.75, and it slowly increased with an increase in training time. The precision and recall of the nerve category were 0.7494 and 0.6587, respectively, and the F1 was 0.7011. From the video prediction, we can observe that the model achieves a high accuracy rate, which could facilitate effective neurorecognition.</p><p><strong>Limitation: </strong>This was a single-center study.</p><p><strong>Conclusion: </strong>The artificial intelligence model for real-time visual neurorecognition in total mesorectal excision was successfully established for the first time in China. Better identification of these autonomic nerves should allow for better preservation of urogenital function, but further research is needed to validate this claim. See Video Abstract.</p>","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diseases of the Colon & Rectum
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1